Rivaroxaban

Rivaroxaban, marketed under the brand name Xarelto, is an anticoagulant medication used to prevent and treat blood clots. It was developed by Bayer AG, a German multinational pharmaceutical and life sciences company. Xarelto is manufactured in multiple countries to meet global demand. Bayer AG remains the ultimate owner of the brand, continuing to innovate in the field of anticoagulation therapy. The medication is widely recognized for its effectiveness in managing conditions such as atrial fibrillation and deep vein thrombosis.